Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.245 USD | +0.33% | -15.78% | -23.32% |
Valuation
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|---|---|
Capitalization 1 | 6.296 | 15.55 | 13.53 | 5.084 | 1.857 | 2.676 | - |
Enterprise Value (EV) 1 | 6.296 | 15.55 | 13.53 | 5.084 | 1.857 | 2.676 | 2.676 |
P/E ratio | -0.49 x | -1.4 x | -0.96 x | -0.44 x | -0.15 x | -0.32 x | 0.15 x |
Yield | - | - | - | - | - | - | - |
Capitalization / Revenue | 300 x | - | - | - | - | - | 0.04 x |
EV / Revenue | 300 x | - | - | - | - | - | 0.04 x |
EV / EBITDA | - | - | - | - | - | - | - |
EV / FCF | - | - | - | - | - | - | - |
FCF Yield | - | - | - | - | - | - | - |
Price to Book | - | - | - | - | - | - | - |
Nbr of stocks (in thousands) | 6.2 | 53.5 | 125 | 127 | 271 | 510.2 | - |
Reference price 2 | 1,016 | 290.5 | 108.0 | 40.18 | 6.840 | 5.245 | 5.245 |
Announcement Date | 26/03/20 | 25/03/21 | 22/03/22 | 22/03/23 | 01/04/24 | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|---|---|
Net sales 1 | 0.021 | - | - | - | - | - | 75 |
EBITDA | - | - | - | - | - | - | - |
EBIT 1 | -8.987 | -8.793 | -13.51 | -11.46 | -10.82 | -9.6 | 62.8 |
Operating Margin | -42,795.24% | - | - | - | - | - | 83.73% |
Earnings before Tax (EBT) 1 | -8.908 | -8.794 | -13.29 | -11.48 | -10.83 | -9.6 | 62.8 |
Net income 1 | -8.908 | -8.794 | -13.29 | -11.48 | -10.83 | -9.6 | 47.7 |
Net margin | -42,419.05% | - | - | - | - | - | 63.6% |
EPS 2 | -2,088 | -207.4 | -112.3 | -90.90 | -46.80 | -16.38 | 34.02 |
Free Cash Flow | - | - | - | - | - | - | - |
FCF margin | - | - | - | - | - | - | - |
FCF Conversion (EBITDA) | - | - | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - | - |
Announcement Date | 26/03/20 | 25/03/21 | 22/03/22 | 22/03/23 | 01/04/24 | - | - |
Income Statement Evolution (Quarterly data)
Fiscal Period: December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales 1 | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
EBIT 1 | -3.45 | -2.64 | -2.521 | -3.571 | -2.73 | - | -2.776 | -1.899 | - | -2.3 | -2.5 | -2.6 |
Operating Margin | - | - | - | - | - | - | - | - | - | - | - | - |
Earnings before Tax (EBT) 1 | -3.451 | -2.642 | -2.531 | -3.576 | -2.731 | - | -2.78 | -1.895 | - | -2.3 | -2.5 | -2.6 |
Net income 1 | -3.451 | -2.642 | -2.531 | -3.576 | -2.731 | -2.549 | -2.78 | -1.895 | -2.154 | -2.3 | -2.5 | -2.6 |
Net margin | - | - | - | - | - | - | - | - | - | - | - | - |
EPS 2 | -28.08 | -20.52 | -20.52 | -28.08 | -21.78 | -13.23 | -10.26 | -1.530 | -4.230 | -4.590 | -4.140 | -3.600 |
Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - |
Announcement Date | 22/03/22 | 12/05/22 | 11/08/22 | 10/11/22 | 22/03/23 | 10/08/23 | 09/11/23 | 01/04/24 | 09/05/24 | - | - | - |
Balance Sheet Analysis
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|---|---|
Net Debt | - | - | - | - | - | - | - |
Net Cash position | - | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | - | - | - | - | - | - | - |
Free Cash Flow | - | - | - | - | - | - | - |
ROE (net income / shareholders' equity) | - | - | - | - | - | - | - |
ROA (Net income/ Total Assets) | - | - | - | - | - | - | - |
Assets 1 | - | - | - | - | - | - | - |
Book Value Per Share | - | - | - | - | - | - | - |
Cash Flow per Share | - | - | - | - | - | - | - |
Capex | - | - | - | - | - | - | - |
Capex / Sales | - | - | - | - | - | - | - |
Announcement Date | 26/03/20 | 25/03/21 | 22/03/22 | 22/03/23 | 01/04/24 | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-23.32% | 2.68M | |
+18.97% | 45.34B | |
+41.98% | 40.42B | |
-10.06% | 37.92B | |
+31.15% | 31.75B | |
-7.79% | 27.71B | |
+13.32% | 26.52B | |
+43.05% | 13.96B | |
+31.28% | 12.44B | |
-7.41% | 11.26B |
- Stock Market
- Equities
- PHIO Stock
- Financials Phio Pharmaceuticals Corp.